Déruaz-Luyet A - Search Results

1

Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology.

Sarri G, Liu W, Zabotka L, Freitag A, Claire R, Wangge G, Elvidge J, Dawoud D, Bennett D, Wen X, Li X, Rentsch CT, Uddin MJ, Ali MS, Gokhale M, Déruaz-Luyet A, Moga DC, Guo JJ, Zullo AR, Patorno E, Lin KJ. Sarri G, et al. Among authors: deruaz luyet a. Clin Pharmacol Ther. 2023 Sep;114(3):604-613. doi: 10.1002/cpt.2977. Epub 2023 Jul 20. Clin Pharmacol Ther. 2023. PMID: 37342987 Review.

2

ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-Offs.

Sarri G, Bennett D, Debray T, Deruaz-Luyet A, Soriano Gabarró M, Largent JA, Li X, Liu W, Lund JL, Moga DC, Gokhale M, Rentsch CT, Wen X, Yanover C, Ye Y, Yun H, Zullo AR, Lin KJ. Sarri G, et al. Clin Pharmacol Ther. 2022 Nov;112(5):990-999. doi: 10.1002/cpt.2560. Epub 2022 Mar 11. Clin Pharmacol Ther. 2022. PMID: 35170021 Free PMC article.

3

Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.

Patorno E, Pawar A, Wexler DJ, Glynn RJ, Bessette LG, Paik JM, Najafzadeh M, Brodovicz KG, Déruaz-Luyet A, Schneeweiss S. Patorno E, et al. Diabetes Obes Metab. 2022 Mar;24(3):442-454. doi: 10.1111/dom.14593. Epub 2021 Dec 1. Diabetes Obes Metab. 2022. PMID: 34729891 Free PMC article.

4

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.

Patorno E, Pawar A, Franklin JM, Najafzadeh M, Déruaz-Luyet A, Brodovicz KG, Sambevski S, Bessette LG, Santiago Ortiz AJ, Kulldorff M, Schneeweiss S. Patorno E, et al. Circulation. 2019 Jun 18;139(25):2822-2830. doi: 10.1161/CIRCULATIONAHA.118.039177. Epub 2019 Apr 8. Circulation. 2019. PMID: 30955357 Free PMC article.

5

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.

Patorno E, Najafzadeh M, Pawar A, Franklin JM, Déruaz-Luyet A, Brodovicz KG, Santiago Ortiz AJ, Bessette LG, Kulldorff M, Schneeweiss S. Patorno E, et al. Endocrinol Diabetes Metab. 2019 Nov 26;3(1):e00103. doi: 10.1002/edm2.103. eCollection 2020 Jan. Endocrinol Diabetes Metab. 2019. PMID: 31922030 Free PMC article.

6

Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.

Desai RJ, Glynn RJ, Everett BM, Schneeweiss S, Wexler DJ, Bessette LG, Déruaz-Luyet A, Vedin O, Brodovicz K, Patorno E. Desai RJ, et al. Am Heart J. 2022 Dec;254:203-215. doi: 10.1016/j.ahj.2022.09.008. Epub 2022 Sep 21. Am Heart J. 2022. PMID: 36150454

7

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.

Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Najafzadeh M, Koeneman L, Farsani SF, Déruaz-Luyet A, Paik JM, Patorno E. Htoo PT, et al. JAMA Netw Open. 2022 Oct 3;5(10):e2237606. doi: 10.1001/jamanetworkopen.2022.37606. JAMA Netw Open. 2022. PMID: 36264574 Free PMC article.

8

Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.

Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ. Nichols GA, et al. BMC Nephrol. 2020 May 28;21(1):200. doi: 10.1186/s12882-020-01854-1. BMC Nephrol. 2020. PMID: 32466752 Free PMC article.

9

Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014.

Déruaz-Luyet A, Raabe C, Garry EM, Brodovicz KG, Lavery LA. Déruaz-Luyet A, et al. Diabetes Obes Metab. 2020 Jul;22(7):1132-1140. doi: 10.1111/dom.14012. Epub 2020 Mar 11. Diabetes Obes Metab. 2020. PMID: 32090430 Free PMC article.

10

Confirming diagnoses of acute pancreatitis with commonly available electronic data.

Nichols GA, Déruaz-Luyet A, Iliev H, Brodovicz KG. Nichols GA, et al. Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):313-319. doi: 10.1002/pds.5185. Epub 2021 Jan 4. Pharmacoepidemiol Drug Saf. 2021. PMID: 33368819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page